+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Medium Borosilicate Glass Vaccine Bottle Market Report: Trends, Forecast and Competitive Analysis to 2035

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Global
  • Lucintel
  • ID: 6293233
The global medium borosilicate glass vaccine bottle market is expected to reach an estimated $12 billion by 2035 from $8 billion in 2027 with a CAGR of 5.1% from 2027 to 2035. The major drivers for this market are the expanding vaccine production and higher demand for multi-dose vials and the rising global vaccination initiatives.

The future of the global medium borosilicate glass vaccine bottle market looks promising with opportunities in the inactivated vaccine and live vaccine markets.
  • Within the type category, 5ml is expected to witness higher growth over the forecast period due to 5ml bottles are widely used for human vaccines such as influenza and hepatitis.
  • Within the application category, inactivated vaccine is expected to witness the higher growth due to more widely used in human and veterinary medicine.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period due to this is due to the country's strong pharmaceutical manufacturing base and high vaccine production volumes.

Emerging Trends in Medium Borosilicate Glass Vaccine Bottle Market

Between 2025 and 2027, the vaccine bottle market will be characterized by increased compliance, barrier performance and supply stability. Vaccine pipelines and regional fill-finish investment, as well as more rigid container specifications, will change procurement. Lucintel believes value will extend beyond lower unit cost to validated packaging.
  • Sustainability: The January 2025 discussion of the European packaging policy continued to encourage pharmaceutical industry supplier reduction of packaging and enhanced material recyclability. Glass has substantial advantages because it is stable and is recycled. Sustainability will change bottle specifications, supplier selection, and the reporting of the lifecycle of the bottle through 2030.
  • Premiumization: Between 2025 and 2027, greater demand for higher-quality Type I containers and tighter dimensional control and more enhanced inspection will occur due to the rising demand for complex biologics and combination vaccines. A 1% higher break rate or rejection will have a greater impact on the economics of fill-finish, thus justifying the investment in a higher-quality premium bottle during the next 3-5 years.
  • Automation: Automated forming, camera inspection, and robotic handling will be standard in most facilities used for vaccine production by 2027. Manufacturers have begun to invest in systems that detect defects and measure dimensions in high-speed production operations. Automation will create consistency throughout large vaccine production campaigns, and it will dramatically reduce the need for employees.
  • Regional Supply Chain Diversification: In 2025, most pharmaceutical companies continued to expand fill-finish operations to include India, Southeast Asia, and the Middle East. New regional demand will favor more local bottle suppliers, managed dual sourcing, and reduced risk due to freight and allocation concerns for the next 5 years.
  • Smart Materials: Bottles are made of more resilient medium-density borosilicate glass and offer greater resistance to hydrolysis in March 2025. An increase in vaccine sensitivity and more extensive regulatory reviews have positive formulation impacts. Extractables-and-leachable are still the focal point in the injection packaging qualification, and more advanced glass compositions and surface treatments are being utilized.
The market is preferring qualification, reliability, and supply resilience over simply having a bottle. Sustainable production, automated inspection, and creditable sustainability data along Type I performance will dominate the market to loyal pharmaceutical clientele. Even though demand will still remain market driven, it will depend increasingly on quality systems, technical support, and valid delivery over the previous volume concentrated market.

Recent Developments in the Medium Borosilicate Glass Vaccine Bottle Market

Medium borosilicate glass vaccine bottle supply is shifting from emergency procurement to qualified, high-throughput requisition. Strong market potential exists across 2025-2027 as vaccine pipelines, regional fill-finish capacity, and stringent container performance requirements redefine market sourcing. Lucintel anticipates growth will be less demand-driven and more oriented towards premium packaging and supply flexibility.
  • Capacity: SCHOTT Pharma plans to invest €100 million to increase its advanced pharmaceutical packaging capacity. By 2025, the additional capacity will support vaccine suppliers requiring quicker delivery times for validated medium borosilicate glass packaging. In the next 3 to 5 years, the regional packaging capacity is expected to decrease the demand on a small number of qualified suppliers.
  • New Technology: Valor Glass, a new technology aimed at improving the break resistance and control of glass particles, was released by Corning. In January 2025, Corning launched the technology for customer use, emphasizing lower breakage, containment loss, and probability of product rejection during high-speed glass vaccine filling.
  • M&A Activity: Gerresheimer completed the integration of Bormioli Pharma in 2025, and this acquisition enhanced the company’s pharmaceutical packaging product and customer offerings. The vertical integration increases capacity for development, regulatory support, and production in various regions, thus increasing competitive pressure on small bottle manufacturers who must now specialize or form alliances.
  • Government Approvals: Additional vaccine manufacturing capacity was approved by the Central Drugs Standard Control Organization in June 2025. Approvals for vaccine manufacturing capacity increase the demand for locally qualified medium borosilicate glass packaging and will encourage packaging suppliers to located technical support near emerging vaccine manufacturing capacity.
  • Strategic Collaboration: In 2025, one of the key vaccine manufacturers collaborated with a glass manufacturer to secure 10-million-dose package supply. These deals will move purchasing from spot buying to multi-year deals and will provide clear visibility of manufacturing capacity to vaccines producers, while creating entry barriers for competing manufacturers.
It will likely remain a capacity-led environment in the medium borosilicate glass vaccine bottle market through 2027. In that case, buyers will favor manufacturers that have validated production and reliable sterilization of glass bottles, as well as regional inventory. Further, the manufacturers of premium glass technologies will gain more market share with the use of sensitive vaccine formulations that can potentially be adversely impacted by glass extractables or breakage. Overall, standard bottles will remain toward the lower end of the pricing spectrum in price-focused markets, but will continue to create further barriers toward entering the market.

Strategic Growth Opportunities in the Medium Borosilicate Glass Vaccine Bottle Market

The medium borosilicate glass vaccine bottle market will continue to grow as pipelines for vaccinations beyond routine immunizations develop. Between 2024 and 2026, the procurement of biologics capacity, fill-finish investment within different regions, and evolving standards on containers will dictate market trends. According to Lucintel, in the future, lines will be won based on the vendor’s glass proven capability of delivering consistent supplies in a flexible format rather than on capacity.
  • Higher-value Biologics Packaging: The demand will likely be for the medium borosilicate glass bottles for vaccines that are adjuvanted, protein-based, or combination vaccines, which require a high level of chemical resistance. In January 2025, the WHO reported more than 150 vaccine candidates that are in clinical trials. The demand for premium glass will be sustained for the next three to five years depending on the type of contracts for the quality of the vaccines.
  • Contract Manufacturing Customers: CDMOs (Contract Development and Manufacturing Organizations) are likely to become the biggest customers of the pharmaceutical industry as companies contract out their filling and packaging. In March 2025, Lonza reported that it had 30 manufacturing sites across the globe. Suppliers that offer regulatory documentation, flexible formats, and quick format changes will likely receive orders from new developers that are likely to be repeat customers.
  • Emerging-market Supply Expansion: Local vaccine production fulfills demand outside North America and Europe. In June 2025, Gavi’s 2025-2030 strategy focused on providing immunization support for 78 lower-income countries. Regional stocking along with technology-transfer programs will provide a consistent demand for standardized medium borosilicate glass vaccine bottles.
  • Low-carbon Container Programs: Pharmaceutical buyers are evaluating vendors based on sustainable packaging and are placing a preference on glass containers that use less glass, more furnace glass, and low emissions. The European Union’s Packaging and Packaging Waste Regulation that went into effect in April 2025 will place a preference on glass containers with reduced emissions.
  • Inspection and Traceability Services: Vaccine manufacturers need greater control over breakage, particle, dimensional variation, and batch genealogy. In February 2025, the Drug Supply Chain Security Act implementation of the FDA required package-level tracing of covered products, and in response vaccine manufacturers can offer integrated vision inspection, serialization support, and digital certificates, which can be used to generate service revenue.
Growth potential is high when vaccine manufacturers consider vaccine container specifications as part of their quality strategy, as opposed to considering container specifications the same as packaging, which can be substituted as needed. Varies specifications will result in chargeable premiums, while standard specifications will ultimately provide the ease of scale and positioning in developing markets. Suppliers must have high furnace efficiency, on-site inspection capability, and strong support. The most advantageous opportunities will be resulting from partnerships with CDMOs, public health organizations, and regional fill-finish facilities.

Medium Borosilicate Glass Vaccine Bottle Market Drivers and Challenges

Market shaping factors for the medium borosilicate glass vaccine bottling include technology progress, the creation of immunization programs, economic factors, expectations concerning sustainability, and changes in pharmaceutical regulations. Increasing demand for vaccines has influenced manufacturers to require containers that are chemically stable, heat-resistant, and resistant to contamination. Costs of operation, the complicated nature of production, supply chain issues, and competition due to alternative forms of packaging, are some of the issues manufacturers are facing. According to Lucintel, the balance between quality, affordability, capacity, and environmental concern will determine the long term success of the pharmaceutical supply chain.

The factors responsible for driving this market include :

  • Increased Demand for Vaccines: The combination of routine vaccination programs, booster shots and offensives aimed at increasing vaccination rates coupled with pandemic planning and the push for vaccination in developing countries has created a constant need for a reliable method of primary packaging. of the different sizes of bottles available to manufacturers, medium sized bottles have an advantage due to their ability to facilitate the efficient completion of the processes of dosing, storage, transport, and filling. During 2025, global health sectors continued to focus on immunization catch up campaigns to reach over one hundred million children. It is expected that new markets will develop within the next three to five years for childhood and other vaccines that cover respiratory and travel diseases and will increase bottle demands and likely increase production capacity.
  • Superior Material Performance: Borosilicate glass demonstrates excellent thermal resistance, low chemical reactivity, dimensional stability, and reduced risk of interaction with sensitive biologic formulations. These attributes are critical for containing pharmaceutical products which may be impacted by extractables, leachable, or container-related stability issues. In March 2025, the H Additional changes related to particle control in injectable packaging highlighted a continuing need for greater control of visible and subvisible particles in injectable containers. In the next three to five years, premium quality medium-borosilicate glass bottles will become the preferred packaging solution to meet the anticipated growth in the markets for complex vaccines and adjuvants along with temperature-sensitive biologics.
  • Regulatory and Quality Requirements: Validated pharmaceutical regulatory container systems demand the protection of product sterility, assurance of product stability, and supply chain traceability. These regulations favor established borosilicate glass formats over less expensive, alternative systems for which additional compatibility will be required. From January 2025 onward, the continued focus of pharmaceutical manufacturing inspections on the integrity of container closures and control of particles for injectable products will impact the industry within the next three to five years, especially within the tighter validation, serialization and quality documentation requirements, thereby creating more barriers to entry, while ensuring fully dependable compliance systems and meeting the needs of qualified suppliers.
  • Efficiency in Manufacturing and Filling: Automation in forming, inspecting, washing, sterilization, and filling have reduced losses and increased consistency. Medium bottles are a good way to meet the capacity and material efficiency demands of multi-dose or bulk packaging for vaccines. In July 2025, a significant number of operations in sterile packaging began to adopt automated systems that inspect hundreds of bottles per minute. It is expected that digital control systems, robotics, and inline defect detection will improve output, reduce waste, and enhance cost competitiveness in the next three to five years.
  • Sustainability and Lifecycle Advantages: Due to its multiple advantages, including protection of the vaccine, glass is inert and can be recycled and offers the vaccine manufacturer a lot of environmental advantages. The use of lightweight glass, in addition to improving furnace operations, recycled glass as well as optimized logistics, can all lead to a significant reduction in the environmental impact of glass bottles. In April 2025, various packaging sustainability programs continued to target an increase of at least 10% of recycled content in pharmaceutical glass supply chain. In the next three to five years, the combination of carbon reporting, customer procurement, and new environmental regulations will promote suppliers to develop low emission processes, as well as lightweight glass bottles.

The challenges facing this market include:

  • Growing Energy and Production Costs: The manufacture of borosilicate glass includes processes of high temperature melting and forming, and thus producers can be negatively impacted by increases in prices of energy, fuel, and labor, and in the cost of raw materials. Add to this the costs of compatibility, visual inspection, dimensional testing, and regulatory qualification. In February 2025, industrial energy prices across several manufacturing regions were considerably higher than they were prior to 2022. The next 3 to 5 years are likely to see increasing volatility in energy costs resulting in higher costs of bottles. This will drive lightweighting efforts and ramp up the deployment of new more efficient furnaces and production across multiple locations, if economically viable.
  • Supply Chain and Capacity Issues: Rapid increases in demand for vaccines create production bottlenecks due to the long lead times required for furnace and tooling capacity, clean rooms, and validation. The sourcing of certain raw materials from a limited number of suppliers can lead to lengthy delivery times for pharmaceutical products. In October 2025, it was noted that global health procurement planning continued to consider reserve production capacity for at least 20 essential vaccine products. The next 3 to 5 years are likely to require manufacturers to have regional production capacity, dual sourcing, and additional capacity to eliminate delivery disruptions and shortages.
  • Alternative Packaging: Polymer containers and cartridges with advanced delivery systems may present lower weight, easier handling, and improved controlled dosing. While these alternatives must comply with strict requirements of compatibility and sterility, such innovations may reduce the demand for conventional bottles for select applications. Prefilled vaccine delivery formats accounted for more than 30 of the new injectable packaging development programs in 2025 and are expected to continue growing. Glass suppliers have until the next three to five years to maintain market share by focusing on convenience, sustainability, and cost in the meantime.
The medium borosilicate glass vaccine bottle market will continue to expand with the increase in vaccine coverage, progress in biologics and pharmaceuticals, and increased demands for pharmaceutical quality. The strength of glass in the cold chain, durable heat resistance, and regulatory acceptance should ensure glass remains important for many years in vaccine packaging. However, alternatives will generate competitive pressure. Balancing the performance of lower cost, resilient, sustainable containers will determine how successfully this market will grow in the future

List of Medium Borosilicate Glass Vaccine Bottle Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies medium borosilicate glass vaccine bottle market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.

Some of the medium borosilicate glass vaccine bottle market companies profiled in this report include:

  • Schott
  • Corning
  • Nippon Electric Glass
  • Shandong Pharmaceutical Glass
  • Zhengchuan

Medium Borosilicate Glass Vaccine Bottle Market by Segment

The study includes a forecast for the global medium borosilicate glass vaccine bottle market by type, application, and region.

Type [Value ($B) from 2019 to 2035]:

  • 2ml
  • 5ml
  • 10ml
  • Others

Application [Value ($B) from 2019 to 2035]:

  • Inactivated Vaccine
  • Live Vaccine
  • Others

Region [Value ($B) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Medium Borosilicate Glass Vaccine Bottle Market

The market for borosilicate glass vaccine bottles is changing because of pharmaceutical localization, stricter container closure standards, and investments in sterile packaging. Between 2025 and 2027, vendors are focusing on high quality glass, ready to use formats, and manufacturing capacity in different regions. These changes will impact the market and compete with Lucintel’s latest market study.
  • United States: The primary focus in the U.S. is on domestic manufacturing and advanced packaging. In January 2025, Corning announced a $1.5 billion investment in U.S. manufacturing over the next three years to support pharmaceutical and other advanced manufacturing initiatives. This will improve the availability of high performance glass in the U.S. and reduce the reliance on supply from other countries.
  • China: The Chinese government’s support of the biopharmaceutical sector is creating demand for locally sourced primary packaging. In April 2025, the Chinese State Council released an action plan with 10 measures for supporting the innovation and development of biopharmaceuticals. The new plan will spur the domestic qualification of medium borosilicate bottle suppliers and will improve capacity in this sector.
  • Germany: European packaging manufacturers are making significant investments in pharmaceutical glass and packaging that meets the needs of injectable drugs. In February 2025, SCHOTT Pharma released first-quarter fiscal-year sales of €232 million, reflecting strong business activity in its global containment portfolio. Germany’s engineering emphasis and manufacturing orientation will impact the market with high quality manufacturing systems and technology.
  • India: Investments in pharmaceutical and vaccination packaging continue. SCHOTT and Kaisha will expand their partnership in India, based in part, on their manufacturing platform in January 2025. The importance of their collaboration is that the domestic supply of medium borosilicate containers is necessary for the Indian vaccine producers’ compliant supply for their national and export programs.
  • Japan: High-quality pharma packaging innovations and glass advancements will continue. For its fiscal year 2024, Nipro reported consolidated net sales of over ¥600 billion, which will allow the company to invest in automation and quality assurance for its medical and pharma segments. They will now have a reliable domestic supply.

Features of the Global Medium Borosilicate Glass Vaccine Bottle Market

  • Market Size Estimates: medium borosilicate glass vaccine bottle market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: medium borosilicate glass vaccine bottle market size by type, application, and region in terms of value ($B).
  • Regional Analysis: medium borosilicate glass vaccine bottle market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the medium borosilicate glass vaccine bottle market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the medium borosilicate glass vaccine bottle market.- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the medium borosilicate glass vaccine bottle market by type (2ml, 5ml, 10ml, and others), application (inactivated vaccine, live vaccine, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain
3. Market Trends & Forecast Analysis
3.1 Global Medium Borosilicate Glass Vaccine Bottle Market Trends and Forecast
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment
4. Global Medium Borosilicate Glass Vaccine Bottle Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 2ml: Trends and Forecast (2019-2035)
4.4 5ml: Trends and Forecast (2019-2035)
4.5 10ml: Trends and Forecast (2019-2035)
4.6 Others: Trends and Forecast (2019-2035)
5. Global Medium Borosilicate Glass Vaccine Bottle Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Inactivated Vaccine: Trends and Forecast (2019-2035)
5.4 Live Vaccine: Trends and Forecast (2019-2035)
5.5 Others: Trends and Forecast (2019-2035)
6. Regional Analysis
6.1 Overview
6.2 Global Medium Borosilicate Glass Vaccine Bottle Market by Region
7. North American Medium Borosilicate Glass Vaccine Bottle Market
7.1 Overview
7.2 North American Medium Borosilicate Glass Vaccine Bottle Market by Type
7.3 North American Medium Borosilicate Glass Vaccine Bottle Market by Application
7.4 United States Medium Borosilicate Glass Vaccine Bottle Market
7.5 Mexican Medium Borosilicate Glass Vaccine Bottle Market
7.6 Canadian Medium Borosilicate Glass Vaccine Bottle Market
8. European Medium Borosilicate Glass Vaccine Bottle Market
8.1 Overview
8.2 European Medium Borosilicate Glass Vaccine Bottle Market by Type
8.3 European Medium Borosilicate Glass Vaccine Bottle Market by Application
8.4 German Medium Borosilicate Glass Vaccine Bottle Market
8.5 French Medium Borosilicate Glass Vaccine Bottle Market
8.6 Spanish Medium Borosilicate Glass Vaccine Bottle Market
8.7 Italian Medium Borosilicate Glass Vaccine Bottle Market
8.8 United Kingdom Medium Borosilicate Glass Vaccine Bottle Market
9. APAC Medium Borosilicate Glass Vaccine Bottle Market
9.1 Overview
9.2 APAC Medium Borosilicate Glass Vaccine Bottle Market by Type
9.3 APAC Medium Borosilicate Glass Vaccine Bottle Market by Application
9.4 Japanese Medium Borosilicate Glass Vaccine Bottle Market
9.5 Indian Medium Borosilicate Glass Vaccine Bottle Market
9.6 Chinese Medium Borosilicate Glass Vaccine Bottle Market
9.7 South Korean Medium Borosilicate Glass Vaccine Bottle Market
9.8 Indonesian Medium Borosilicate Glass Vaccine Bottle Market
10. RoW Medium Borosilicate Glass Vaccine Bottle Market
10.1 Overview
10.2 RoW Medium Borosilicate Glass Vaccine Bottle Market by Type
10.3 RoW Medium Borosilicate Glass Vaccine Bottle Market by Application
10.4 Middle Eastern Medium Borosilicate Glass Vaccine Bottle Market
10.5 South American Medium Borosilicate Glass Vaccine Bottle Market
10.6 African Medium Borosilicate Glass Vaccine Bottle Market
11. Competitor Analysis
11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter’s Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
11.4 Market Share Analysis
12. Opportunities & Strategic Analysis
12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
12.2.1 Growth Opportunities by Type
12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Medium Borosilicate Glass Vaccine Bottle Market
12.4 Strategic Analysis
12.4.1 New Product Development
12.4.2 Certification and Licensing
12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures
13. Company Profiles of the Leading Players Across the Value Chain
13.1 Competitive Analysis
13.2 Schott
  • Company Overview
  • Medium Borosilicate Glass Vaccine Bottle Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
13.3 Corning
  • Company Overview
  • Medium Borosilicate Glass Vaccine Bottle Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
13.4 Nippon Electric Glass
  • Company Overview
  • Medium Borosilicate Glass Vaccine Bottle Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
13.5 Shandong Pharmaceutical Glass
  • Company Overview
  • Medium Borosilicate Glass Vaccine Bottle Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
13.6 Zhengchuan
  • Company Overview
  • Medium Borosilicate Glass Vaccine Bottle Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
14. Appendix
14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us
List of Figures
Chapter 1
Figure 1.1: Trends and Forecast for the Global Medium Borosilicate Glass Vaccine Bottle Market
Chapter 2
Figure 2.1: Usage of Medium Borosilicate Glass Vaccine Bottle Market
Figure 2.2: Classification of the Global Medium Borosilicate Glass Vaccine Bottle Market
Figure 2.3: Supply Chain of the Global Medium Borosilicate Glass Vaccine Bottle Market
Chapter 3
Figure 3.1: Driver and Challenges of the Medium Borosilicate Glass Vaccine Bottle Market
Figure 3.2: PESTLE Analysis
Figure 3.3: Patent Analysis
Figure 3.4: Regulatory Environment
Chapter 4
Figure 4.1: Global Medium Borosilicate Glass Vaccine Bottle Market by Type in 2019, 2026, and 2035
Figure 4.2: Trends of the Global Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type
Figure 4.3: Forecast for the Global Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type
Figure 4.4: Trends and Forecast for 2ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Figure 4.5: Trends and Forecast for 5ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Figure 4.6: Trends and Forecast for 10ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Figure 4.7: Trends and Forecast for Others in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Chapter 5
Figure 5.1: Global Medium Borosilicate Glass Vaccine Bottle Market by Application in 2019, 2026, and 2035
Figure 5.2: Trends of the Global Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application
Figure 5.3: Forecast for the Global Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application
Figure 5.4: Trends and Forecast for Inactivated Vaccine in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Figure 5.5: Trends and Forecast for Live Vaccine in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Figure 5.6: Trends and Forecast for Others in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Chapter 6
Figure 6.1: Trends of the Global Medium Borosilicate Glass Vaccine Bottle Market ($B) by Region (2019-2026)
Figure 6.2: Forecast for the Global Medium Borosilicate Glass Vaccine Bottle Market ($B) by Region (2027-2035)
Chapter 7
Figure 7.1: North American Medium Borosilicate Glass Vaccine Bottle Market by Type in 2019, 2026, and 2035
Figure 7.2: Trends of the North American Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2019-2026)
Figure 7.3: Forecast for the North American Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2027-2035)
Figure 7.4: North American Medium Borosilicate Glass Vaccine Bottle Market by Application in 2019, 2026, and 2035
Figure 7.5: Trends of the North American Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2019-2026)
Figure 7.6: Forecast for the North American Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2027-2035)
Figure 7.7: Trends and Forecast for the United States Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 7.8: Trends and Forecast for the Mexican Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 7.9: Trends and Forecast for the Canadian Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Chapter 8
Figure 8.1: European Medium Borosilicate Glass Vaccine Bottle Market by Type in 2019, 2026, and 2035
Figure 8.2: Trends of the European Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2019-2026)
Figure 8.3: Forecast for the European Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2027-2035)
Figure 8.4: European Medium Borosilicate Glass Vaccine Bottle Market by Application in 2019, 2026, and 2035
Figure 8.5: Trends of the European Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2019-2026)
Figure 8.6: Forecast for the European Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2027-2035)
Figure 8.7: Trends and Forecast for the German Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 8.8: Trends and Forecast for the French Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 8.9: Trends and Forecast for the Spanish Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 8.10: Trends and Forecast for the Italian Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 8.11: Trends and Forecast for the United Kingdom Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Chapter 9
Figure 9.1: APAC Medium Borosilicate Glass Vaccine Bottle Market by Type in 2019, 2026, and 2035
Figure 9.2: Trends of the APAC Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2019-2026)
Figure 9.3: Forecast for the APAC Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2027-2035)
Figure 9.4: APAC Medium Borosilicate Glass Vaccine Bottle Market by Application in 2019, 2026, and 2035
Figure 9.5: Trends of the APAC Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2019-2026)
Figure 9.6: Forecast for the APAC Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2027-2035)
Figure 9.7: Trends and Forecast for the Japanese Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 9.8: Trends and Forecast for the Indian Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 9.9: Trends and Forecast for the Chinese Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 9.10: Trends and Forecast for the South Korean Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 9.11: Trends and Forecast for the Indonesian Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Chapter 10
Figure 10.1: RoW Medium Borosilicate Glass Vaccine Bottle Market by Type in 2019, 2026, and 2035
Figure 10.2: Trends of the RoW Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2019-2026)
Figure 10.3: Forecast for the RoW Medium Borosilicate Glass Vaccine Bottle Market ($B) by Type (2027-2035)
Figure 10.4: RoW Medium Borosilicate Glass Vaccine Bottle Market by Application in 2019, 2026, and 2035
Figure 10.5: Trends of the RoW Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2019-2026)
Figure 10.6: Forecast for the RoW Medium Borosilicate Glass Vaccine Bottle Market ($B) by Application (2027-2035)
Figure 10.7: Trends and Forecast for the Middle Eastern Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 10.8: Trends and Forecast for the South American Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Figure 10.9: Trends and Forecast for the African Medium Borosilicate Glass Vaccine Bottle Market ($B) (2019-2035)
Chapter 11
Figure 11.1: Porter’s Five Forces Analysis of the Global Medium Borosilicate Glass Vaccine Bottle Market
Figure 11.2: Market Share (%) of Top Players in the Global Medium Borosilicate Glass Vaccine Bottle Market (2026)
Chapter 12
Figure 12.1: Growth Opportunities for the Global Medium Borosilicate Glass Vaccine Bottle Market by Type
Figure 12.2: Growth Opportunities for the Global Medium Borosilicate Glass Vaccine Bottle Market by Application
Figure 12.3: Growth Opportunities for the Global Medium Borosilicate Glass Vaccine Bottle Market by Region
Figure 12.4: Emerging Trends in the Global Medium Borosilicate Glass Vaccine Bottle Market
List of Tables
Chapter 1
Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Medium Borosilicate Glass Vaccine Bottle Market by Type and Application
Table 1.2: Attractiveness Analysis for the Medium Borosilicate Glass Vaccine Bottle Market by Region
Table 1.3: Global Medium Borosilicate Glass Vaccine Bottle Market Parameters and Attributes
Chapter 3
Table 3.1: Trends of the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 3.2: Forecast for the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Chapter 4
Table 4.1: Attractiveness Analysis for the Global Medium Borosilicate Glass Vaccine Bottle Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 4.3: Market Size and CAGR of Various Type in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 4.4: Trends of 2ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 4.5: Forecast for 2ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 4.6: Trends of 5ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 4.7: Forecast for 5ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 4.8: Trends of 10ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 4.9: Forecast for 10ml in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 4.10: Trends of Others in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 4.11: Forecast for Others in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Chapter 5
Table 5.1: Attractiveness Analysis for the Global Medium Borosilicate Glass Vaccine Bottle Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 5.3: Market Size and CAGR of Various Application in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 5.4: Trends of Inactivated Vaccine in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 5.5: Forecast for Inactivated Vaccine in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 5.6: Trends of Live Vaccine in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 5.7: Forecast for Live Vaccine in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 5.8: Trends of Others in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 5.9: Forecast for Others in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Chapter 6
Table 6.1: Market Size and CAGR of Various Regions in the Global Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 6.2: Market Size and CAGR of Various Regions in the Global Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Chapter 7
Table 7.1: Trends of the North American Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 7.2: Forecast for the North American Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 7.3: Market Size and CAGR of Various Type in the North American Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 7.4: Market Size and CAGR of Various Type in the North American Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 7.5: Market Size and CAGR of Various Application in the North American Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 7.6: Market Size and CAGR of Various Application in the North American Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 7.7: Trends and Forecast for the United States Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 7.8: Trends and Forecast for the Mexican Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 7.9: Trends and Forecast for the Canadian Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Chapter 8
Table 8.1: Trends of the European Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 8.2: Forecast for the European Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 8.3: Market Size and CAGR of Various Type in the European Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 8.4: Market Size and CAGR of Various Type in the European Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 8.5: Market Size and CAGR of Various Application in the European Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 8.6: Market Size and CAGR of Various Application in the European Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 8.7: Trends and Forecast for the German Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 8.8: Trends and Forecast for the French Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 8.9: Trends and Forecast for the Spanish Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 8.10: Trends and Forecast for the Italian Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 8.11: Trends and Forecast for the United Kingdom Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Chapter 9
Table 9.1: Trends of the APAC Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 9.2: Forecast for the APAC Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 9.3: Market Size and CAGR of Various Type in the APAC Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 9.4: Market Size and CAGR of Various Type in the APAC Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 9.5: Market Size and CAGR of Various Application in the APAC Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 9.6: Market Size and CAGR of Various Application in the APAC Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 9.7: Trends and Forecast for the Japanese Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 9.8: Trends and Forecast for the Indian Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 9.9: Trends and Forecast for the Chinese Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 9.10: Trends and Forecast for the South Korean Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 9.11: Trends and Forecast for the Indonesian Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Chapter 10
Table 10.1: Trends of the RoW Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 10.2: Forecast for the RoW Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 10.3: Market Size and CAGR of Various Type in the RoW Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 10.4: Market Size and CAGR of Various Type in the RoW Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 10.5: Market Size and CAGR of Various Application in the RoW Medium Borosilicate Glass Vaccine Bottle Market (2019-2026)
Table 10.6: Market Size and CAGR of Various Application in the RoW Medium Borosilicate Glass Vaccine Bottle Market (2027-2035)
Table 10.7: Trends and Forecast for the Middle Eastern Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 10.8: Trends and Forecast for the South American Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Table 10.9: Trends and Forecast for the African Medium Borosilicate Glass Vaccine Bottle Market (2019-2035)
Chapter 11
Table 11.1: Product Mapping of Medium Borosilicate Glass Vaccine Bottle Suppliers Based on Segments
Table 11.2: Operational Integration of Medium Borosilicate Glass Vaccine Bottle Manufacturers
Table 11.3: Rankings of Suppliers Based on Medium Borosilicate Glass Vaccine Bottle Revenue
Chapter 12
Table 12.1: New Product Launches by Major Medium Borosilicate Glass Vaccine Bottle Producers (2019-2026)
Table 12.2: Certification Acquired by Major Competitor in the Global Medium Borosilicate Glass Vaccine Bottle Market

Companies Mentioned

  • Schott
  • Corning
  • Nippon Electric Glass
  • Shandong Pharmaceutical Glass
  • Zhengchuan

Methodology

The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:

  • In-depth interviews of the major players in the market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.

Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.

Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

 

Loading
LOADING...